Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | PNLIP | P16233 | 1/20 | 0.33 |
| ▸ | UGT2B7 | P16662 | 5/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5704147 | 0.86 | ALDH1A1 (0.64) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL4776113 | 0.81 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL5704327 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL4780642 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL18949251 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL16984792 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL18216691 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL16816912 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL16816911 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL16984810 | 0.81 | ALDH1A1 (0.60) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250290009-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2025-09-18 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| EP-4522714-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | Firmenich SA (CH) | 2025-03-19 | — | — | EP | disclosed |
| US-20250002947-A1 | RECOMBINANT MANUFACTURE OF C-20 TERPENOID ALCOHOLS | ISOBIONICS B.V. (NL) | 2025-01-02 | — | — | US | disclosed |
| CN-119173616-A | Recovery of novel low sulfur terpene mixtures from wood processing | 弗门尼舍有限公司 | 2024-12-20 | — | — | CN | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20230293480-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-20230219015-A1 | EXTRACTION METHOD AND MIXTURE OF SUBSTANCES | K.D. PHARMA BEXBACH GMBH (DE) | 2023-07-13 | — | — | US | disclosed |
| EP-4203984-A1 | EXTRACTION METHOD AND MIXTURE OF SUBSTANCES | K.D. Pharma Bexbach GmbH (DE) | 2023-07-05 | — | — | EP | disclosed |
| US-11684604-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2023-06-27 | — | — | US | disclosed |
| WO-2023280677-A1 | RECOMBINANT MANUFACTURE OF C-20 TERPENOID ALCOHOLS | ISOBIONICS B.V. (NL) | 2023-01-12 | — | — | WO | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
| WO-2022043422-A1 | EXTRACTION METHOD AND MIXTURE OF SUBSTANCES | K.D. PHARMA BEXBACH GMBH (DE) | 2022-03-03 | — | — | WO | disclosed |
| US-20200229370-A1 | HYBRID TOBACCO PLANTS FROM CROSSES BETWEEN FLUE-CURED AND AIR-CURED TOBACCO TYPES | SOUZA CRUZ LTDA (BR) | 2020-07-23 | — | — | US | disclosed |
| EP-3651567-A1 | HYBRID TOBACCO PLANTS FROM CROSSES BETWEEN FLUE-CURED AND AIR-CURED TOBACCO TYPES | British American Tobacco (Investments) Limited (GB) | 2020-05-20 | — | — | EP | disclosed |
| WO-2019012261-A1 | HYBRID TOBACCO PLANTS FROM CROSSES BETWEEN FLUE-CURED AND AIR-CURED TOBACCO TYPES | BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED (GB) | 2019-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684604-B2 | Cannabis based therapeutic and method of use | CNR2, CNR1, OPRK1 | ALDH1A1 3206/4885CYP3A4 2613/4885CYP2C9 866/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ALDH1A1 1420/4885CYP3A4 1136/4885CYP2C9 261/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ALDH1A1 4768/4885CYP3A4 1979/4885CYP2C9 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.